95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.44%
Revenue growth above 1.5x AEM's 2.34%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
60.21%
Gross profit growth above 1.5x AEM's 8.97%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-31.17%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-33.15%
Negative operating income growth while AEM is at 5.97%. Joel Greenblatt would press for urgent turnaround measures.
-43.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-44.12%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-44.12%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.25%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.01%
Diluted share reduction more than 1.5x AEM's 0.42%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.19%
Maintaining or increasing dividends while AEM cut them. John Neff might see a strong edge in shareholder returns.
25.61%
OCF growth above 1.5x AEM's 3.93%. David Dodd would confirm a clear edge in underlying cash generation.
-8.90%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
121.58%
10Y revenue/share CAGR 1.25-1.5x AEM's 87.80%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
68.26%
5Y revenue/share CAGR above 1.5x AEM's 41.33%. David Dodd would look for consistent product or market expansions fueling outperformance.
35.77%
3Y revenue/share CAGR above 1.5x AEM's 14.62%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
177.46%
10Y OCF/share CAGR in line with AEM's 193.31%. Walter Schloss would see both as similarly efficient over the decade.
139.14%
5Y OCF/share CAGR 1.25-1.5x AEM's 110.41%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
62.38%
3Y OCF/share CAGR at 50-75% of AEM's 111.57%. Martin Whitman would suspect weaker recent execution or product competitiveness.
38.48%
Below 50% of AEM's 1116.65%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
12.23%
Positive 5Y CAGR while AEM is negative. John Neff might view this as a strong mid-term relative advantage.
-70.02%
Negative 3Y CAGR while AEM is 142.31%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
63.53%
10Y equity/share CAGR at 50-75% of AEM's 117.56%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
34.54%
Below 50% of AEM's 95.08%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
15.29%
Below 50% of AEM's 69.87%. Michael Burry suspects a serious short-term disadvantage in building book value.
235.15%
10Y dividend/share CAGR at 50-75% of AEM's 405.65%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
103.88%
5Y dividend/share CAGR at 50-75% of AEM's 143.37%. Martin Whitman might see a lagging policy in mid-term shareholder returns.
21.23%
3Y dividend/share CAGR similar to AEM's 22.25%. Walter Schloss finds parallel short-term dividend strategies for both companies.
-47.47%
Firm’s AR is declining while AEM shows 15.59%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.52%
Asset growth at 50-75% of AEM's 0.73%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
0.24%
Under 50% of AEM's 2.05%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-8.70%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-11.40%
We cut SG&A while AEM invests at 27.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.